Navigation

🏠 Home 📰 Latest News 🌍 World 🇮🇳 India 💼 Business 💻 Technology ⚽ Sports 🎬 Entertainment 🏥 Health
Biggest News Aggregation in the World
📰 Featured Research Session News

Featured Research Session News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Featured Research Session. Real-time updates on events, politics, business and more.

Acumen Pharmaceuticals, Inc. Presents Positive Topline Results from First-in-Human Phase 1 Study of ACU193 for Early Alzheimer’s Disease at the Alzheimer’s Association International Conference 2023

July 17, 2023
Acumen Pharmaceuticals, Inc.  presented positive topline results from the Phase 1 INTERCEPT-AD trial of ACU193, the first clinical-stage AßO targeting antibody therapy in early AD, at the...
Noord Holland Acumen Pharmaceuticals Inc Association International Conference Research Session Acumen Pharmaceuticals Statistically Significant Amyloid Plaque
Source: marketscreener.com

Acumen Pharmaceuticals to Present Topline Results from First-in-Human Phase 1 Study of ACU193 for Early Alzheimer's Disease During Featured Research Session at the Alzheimer's Association International Conference (AAIC®) 2023

June 13, 2023
Topline results for ACU193, the first clinical stage amyloid beta oligomer -directed antibody, to provide deeper insight into candidate’s therapeutic potential for the treatment of early... | June 13, 2023
Noord Holland New York United States Kimball Johnson Steven Dekosky Eric Siemers
Source: marketscreener.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science